Articles

Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent Pharmaceuticals private label.

Teva and Alvotech Further Strengthen Their Relationship, Reach Biosimilar Commercialization Deal

Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.

A Look at the Effects of the Inflation Reduction Act 

The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.

Kenco, QPharma Collaborate on Improving Supply Chain Challenges

The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.

 Sygnature Discovery Given Award for Sustainability

IATA data points to a fourth consecutive month of double-digit, year-on-year growth. 

Air Freight Demand Continues Its Climb in March

The merger exponentially grows ONO’s oncology pipeline.

ONO Pharmaceutical Solidifies $2.4 Billion Acquisition of Deciphera

The complex will research solutions for manufacturing antibodies, mRNA applications, and more. 

Merck KGaA Financially Commits $322 Million Toward Research Center

A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more. 

The Relationship Between Cold Chain Logistics and Cell & Gene Therapies

The CDMO’s boost in production will be centered around pharmaceutical products.

Berry Global Increases Manufacturing Capacity

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

News